Data as of Q4 2025 (Dec 31, 2025)

FCPM III SERVICES B.V.

โ€ขCIK: 2013410โ€ขFiling: Q4 2025

**FCPM III SERVICES B.V.** manages $763M across a concentrated portfolio of 10 positions. The fund exhibits a significant overweight to **VYLD**, representing $322.7M of its assets. Further notable allocations include **DYN** at $106.9M and **ENGN** at $87.0M. This structure suggests a targeted, high-conviction approach across its core holdings.

Total AUM
$762.9M
QoQ Performance
+52.5%
Positions
9
Top 10 Concentration
100.0%
Latest Filing
Q4 2025

Top Holdings Allocation

NAMS
DYN
ENGN
RAPT
MPLT
VOR
NAMS42.3%
DYN14.0%
ENGN11.4%
RAPT8.1%
MPLT7.4%
VOR6.2%
REPL3.6%
BCYC3.2%

๐Ÿ“ˆ Biggest Buys

MPLT
MAPLIGHT THERAPEUTICS INC
NEW
7.4% of portfolio
RAPT
RAPT THERAPEUTICS INC
+432.6%
8.1% of portfolio
VOR
VOR BIOPHARMA INC
+852.8%
6.2% of portfolio
โ€”
CRESCENT BIOPHARMA INC.
NEW
2.6% of portfolio
BCYC
BICYCLE THERAPEUTICS PLC
+0.5%
3.2% of portfolio

๐Ÿ“‰ Biggest Sells

REPL
REPLIMUNE GROUP INC
-32.5%
3.6% of portfolio
NAMS
NEWAMSTERDAM PHARMA COMPANY
-0.1%
42.3% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

CATBUSD
ASTRIA THERAPEUTICS INC
SOLD
$29.9M

Changes from Q3 2025

NEW2 new positions
โ†‘3 increased
โ†“2 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023